GT Healthcare backs biotech firm Apeiron
Shanghai-based Apeiron, a biotech company, has launched with $27 million. The investors included GT Healthcare.
11 June 2019•3 mins read
Shanghai-based Apeiron, a biotech company, has launched with $27 million. The investors included GT Healthcare.
Genstar Capital exits Obsidian in sale to Daiichi Life-owned Protective
40 minutes ago · 1 min read
EQT Infrastructure-backed SatPort acquires Speedcast’s teleport business, adding 12 sites
42 minutes ago · 1 min read
O2 Investment Partners exits Xobee Networks via sale to Sole Source-backed Brite
1 hour ago · 1 min read
Francisco Partners and KKR to take minority stakes in H&F-backed TeamSystem
2 hours ago · 2 mins read
Carlyle and PAI Partners agree to sell Theramex to Cinven
3 hours ago · 1 min read
Hg agrees to back new European AI transformation firm alongside Anthropic
3 hours ago · 1 min read
KKR-backed CIRCOR agrees to acquire Italian pump maker Green Silence Group
3 hours ago · 1 min read
